Antimicrobial susceptibility of 103 strains of Haemophilus ducreyi isolated in Johannesburg.

Antimicrobial Agents and Chemotherapy
Y R BilgeriH J Koornhof

Abstract

Of 103 strains of Haemophilus ducreyi isolated in Johannesburg, 96 produced beta-lactamase and were resistant to penicillin and ampicillin. Most strains showed resistance to tetracycline, sulfisoxazole, and sulfamethoxazole. All isolates were susceptible to rifampin, erythromycin, and cefoxitin, moderately susceptible to trimethoprim-sulfamethoxazole (1:19) and minocycline, and somewhat less susceptible to doxycycline.

References

Mar 24, 1979·Lancet·L Lykke-OlesenK Gaarslev
Apr 1, 1978·Antimicrobial Agents and Chemotherapy·G W HammondA R Ronald
Feb 1, 1979·Antimicrobial Agents and Chemotherapy·J L BruntonW L Albritton
Dec 1, 1979·International Journal of Dermatology·A H Rudolph
May 1, 1979·The Journal of Antimicrobial Chemotherapy·G W HammondA R Ronald
Nov 1, 1979·The Journal of Antimicrobial Chemotherapy·P J Wilkinson, D S Reeves
Mar 1, 1976·Journal of General Microbiology·M Kilian
Apr 1, 1972·Antimicrobial Agents and Chemotherapy·C H O'CallaghanA H Shingler
May 1, 1972·The Journal of Urology·J L Marmar
Nov 1, 1969·Archives of Dermatology·R E KerberK R Gilbert
Dec 1, 1981·The British Journal of Venereal Diseases·H NsanzeA Ronald
May 1, 1980·Antimicrobial Agents and Chemotherapy·I W MacLeanW L Albritton
Jul 1, 1981·Sexually Transmitted Diseases·J L CarpenterT Oberhoffer
Dec 1, 1981·The British Journal of Venereal Diseases·S HafizM G McEntegart
Oct 1, 1982·Antimicrobial Agents and Chemotherapy·J A Thomson, Y R Bilgeri

❮ Previous
Next ❯

Citations

Oct 1, 1992·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·Y DangorR C Ballard
Oct 1, 1982·Antimicrobial Agents and Chemotherapy·J A Thomson, Y R Bilgeri
Sep 1, 1988·Antimicrobial Agents and Chemotherapy·Y DangorH J Koornhof
Aug 1, 1983·The British Journal of Venereal Diseases·M O DuncanR C Ballard
Jan 1, 1989·Genitourinary Medicine·R C BallardA S Latif
Jun 1, 1996·Genitourinary Medicine·G B Pham-KanterR C Ballard
Mar 1, 1985·Mayo Clinic Proceedings·J A Washington, W R Wilson
May 1, 1985·Infection Control : IC·J A Daly
May 18, 2012·Dermatologic Therapy·Susan Y ChonStephen K Tyring
Aug 1, 1987·Histopathology·A L Freinkel
Apr 1, 1995·Genitourinary Medicine·B Kumar, G Dawn
Jul 1, 1995·Clinical Microbiology Reviews·D L Trees, S A Morse
Apr 1, 1989·Clinical Microbiology Reviews·S A Morse
Jul 1, 1990·Antimicrobial Agents and Chemotherapy·Y DangorH J Koornhof

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.